Blockman, MCohen, KDe Waal, RGray, AKredo, TMaartens, GNel, JParrish, ARees, HReubenson, G2024-09-262024-09-262021-04-09https://www.health.gov.za/wp-content/uploads/2020/12/Rapid-review-of-Azithromycin-for-COVID-19_11May2020.pdfhttps://hdl.handle.net/11288/597532Azithromycin is currently included in many South African standard treatment guidelines, including for the treatment of bacterial infections in penicillin-allergic patients, for rickettsial infections in patients unable to take tetracyclines, and specifically for the management of atypical bacterial infections, including nosocomial pneumonia.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Macrolide antibioticDrugs and supplementsSARS-CoV-2ZithromaxPharmacokineticsPharmacologyAzithromycinAntibioticAzithromycin for COVID-19: Evidence review of the clinical benefit and harmTechnical Report